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Selected ion flow tube mass spectrometry, SIFT-MS, has been used to determine the repeatability
of the analysis of volatile metabolites within the breath of healthy volunteers, with emphasis on the
influence of sampling methodology. Baseline instrument specific coefficients of variability for
examined metabolites were as follows: acetone (1%), ammonia (1%), isoprene (2%), propanol (6%),
ethanol (7%), acetic acid (7%), and hydrogen cyanide (19%). Metabolite concentration and related
product ion count rate were identified as strong determinants of measurement variation. With the
exception of ammonia, an orally released metabolite, variability in repeated on-line breath analysis
tended to be lower for metabolites of systemic origin. Standardization of sampling technique
improved the repeatability of the analysis of selected metabolites. Off-line (bag) alveolar breath
sampling, as opposed to mixed (whole) breath sampling, likewise improved the repeatability of the
analysis of all metabolites investigated, with the exception of acetic acid. We conclude that SIFT-MS
analysis of common volatile metabolites within the breath of healthy volunteers is both reliable and
repeatable. For selected metabolites, the finding that repeatability is improved through modifica-
tion of sampling methodology may have implications in terms of future recommended
practices. (J Am Soc Mass Spectrom 2010, 21, 1070–1074) © 2010 American Society for Mass
SpectrometryThe analysis of volatile metabolites within exhaledbreath is a promising field of medical researchoffering a safe and noninvasive approach to dis-
ease diagnosis and therapeutic monitoring. In spite of
those potential advantages, the invasive collection and
analysis of human body fluids and tissues remains the
cornerstone in modern medical practice. Historic diffi-
culties associated with accurate and reliable detection of
volatile metabolites at levels characteristic of exhaled
breath, typically equivalent to parts-per-million (ppm)
and parts-per-billion (ppb), are partly responsible for
the limited success of clinical breath testing. Recent
advances have, however, overcome these issues and
have led to the development of techniques such as
selected ion flow tube mass spectrometry, SIFT-MS,
which combines quantitative mass spectrometry and
fast flow tube techniques [1]. By this approach, on-line
and real time detection of a range of metabolites within
a single exhalation can be achieved. Nevertheless, there
remains an important requirement to determine the
degree of instrument-specific variability in measuring
different exhaled metabolites. Likewise, the influence of
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Such information is essential as it will help support both
appropriate selection of sampling methodology and
interpretation of whether an observed difference in
repeated measurements is likely to represent a true
change in clinical status.
In this communication, we investigate the repeat-
ability of the measurement of prominent exhaled
metabolites in healthy subjects using SIFT-MS.
Methods
Breath Sampling Methodology
Breath samples were analyzed using the multiple ion
monitoring (MIM) mode of the Profile-3 SIFT-MS in-
strument (Instrument Science, Crewe, UK), a full de-
scription of which is provided elsewhere [1]. Breath
samples were collected by asking subjects to inhale
deeply, close to total lung capacity, and to then
promptly provide a complete exhalation into the sam-
pling device. Calculation of metabolite concentration
within on-line breath samples was performed by inte-
gration over the duration of the expiratory plateau.
Alternatively, calculation of metabolite concentrations
within off-line (bag) samples was performed by deter-
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samples were left for a period of 1 h before analysis,
reflecting the average duration between sampling and
analysis commonly observed within the clinical setting.
With the exception of water content, breath samples are
stable during this period [2]. To eliminate condensation,
all sample lines were heated and off-line samples were
placed within an incubator held at 37 °C both 5 min
before and for the duration of the analysis.
Breath metabolites investigated in the present study
were as follows: acetone, ethanol, propanol, ammonia,
hydrogen cyanide, isoprene, and acetic acid. The quan-
tification of these metabolites by SIFT-MS has been
previously described [3, 4].
Analysis of repeatability was performed on log-
transformed data through computation of Lin’s concor-
dance correlation coefficient [5] and the mean intra-
individual coefficient of variability, determined as the
average ratio of the standard deviation and the mean of
paired datasets. Use of log-transformed data is in ac-
cordance with previous studies which show the concen-
trations of common breath metabolites follow more
closely a log-normal distribution [6].
Experiment I: Instrument-Specific Variability
Healthy subjects (n  10) were asked to provide single
mixed (whole) breath samples by exhaling directly into
single-use sample bags (2 L) constructed from double
thickness (2  25 m) Nalophan (Kalle UK Ltd.,
Witham, UK). Metabolites within collected samples
were analyzed, and immediately (10 s) re-analyzed to
assess instrument specific variability. Changes in sam-
ple metabolite composition between repeat analyses
were considered to be negligible.
Experiment II: On-Line Control of Expiratory
Pressure and Flow
Healthy subjects (n  10) were requested to exhale into
the entry port of the SIFT-MS instrument. Volatile
metabolites were analyzed within three repeat breaths.
This process was repeated using a standardized proto-
col, for which the entry port of the SIFT-MS instrument
was integrated with an independent LR2500 multiple-
gas analyzer (Logan Research Ltd., Rochester, UK), the
latter allowing expiratory flow rate and mouth pressure
to be set at 50 mL/s and 5 cm H2O, respectively
(Figure S1 available as supplementary material, which
can be found in the electronic version of this article).
Experiment III: Off-Line Sampling from Different
Respiratory Tract Compartments
The repeatability of two off-line breath sampling meth-
odologies was assessed. Mixed off-line breath samples(n  2) were collected in short succession from 10
healthy volunteers. Alveolar breath samples (n  2)
were collected from 10 healthy volunteers using a CO2
triggered ‘alveolar’ breath sampler (developed at Inns-
bruck Medical University, Innsbruck, Austria), within
which Nalophan sample bags were placed (Figure S2
available as supplementary material). At the prese-
lected activation threshold, 4% CO2, an average of three
exhalations were required to collect a sample of 2 L.
Results and Discussion
Subjects
Sixteen healthy, non-smoking subjects (4 female and 12
male; 29 7 y) were enrolled to take part in one or more
of the proposed studies. Testing by one-way ANOVA
showed no significant difference in the mean age,
height, weight, body mass index (BMI), or time since
last oral intake between subjects participating in differ-
ent experiments.
Experiment I
The repeatability of SIFT-MS was examined through the
immediate re-analysis of mixed breath samples. Excel-
lent repeatability, as indicated by a Lin’s concordance
coefficient, Rc, 0.9 [5] was observed for the major
breath metabolites acetone, isoprene and ammonia (Ta-
ble 1). For all metabolites examined observed mean
coefficients of variability (Cv), were 20%. Plotting Cv
as a function of total product ion count rate and
concentration (Figure 1) established signal intensity as a
key determinant of measurement variation. In addition,
the predicted measurement error, determined by the
instrument software from the total number of counts
recorded [7], matched approximately the observed dif-
ference (bias) between repeated analyses’ of the same
sample. It was also noted that the repeat analysis of a
sample tended to yield higher metabolite concentra-
tions, as indicated by a negative bias. As only a few
samples were investigated, the significance of this find-
ing remains uncertain. It may, however, be the case that
there is an initial loss of sample onto the clean surfaces
of the instrument. Further investigation of instrument-
specific variability using accurately known gas stan-
dards is therefore recommended. As intra-day and
inter-day repeatability of the instrument were not in-
vestigated, further work is also required in this regard.
Experiment II
To investigate the influence of standardization of expi-
ratory pressure and flow, a custom manifold was de-
veloped to allow control of these parameters. Median
values and repeatability statistics are presented in Table 2.
Results suggest that standardization can improve re-
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cyanide, and isoprene. Although these findings may
reflect a reduction in the influence of methodological
sources of variability; the precise mechanisms whereby
such effects are mediated remain uncertain.
The site of release of breath metabolites within the
airways and its relation to the chosen sampling meth-
odology may contribute to observed variability. Several
recent publications comparing metabolite levels in
mouth- and nose-exhaled breath and within the oral
cavity, would support this hypothesis [3]. The findings
of the current investigations suggest that for breath
metabolites of presumed systemic origin, acetone and
isoprene [3], measured on-line by non-standardized
methods, Cv tends to be lower in comparison to orally
released compounds, with the notable exception of
ammonia. These results are, however, best explained by
differences in the concentrations of these metabolites
within the breath rather than their site of release (refer
to the findings of Experiment I).
Ethanol, propanol, hydrogen cyanide, and acetic acid
were found in higher concentrations within breath
Figure 1. Scatter plots of the mean coefficie
recorded product ion count and (b) ppb level, r
Table 1. Instrument specific variability
Precursor ions Product ion(s)
M
ppb
Acetone [H3O] 59,77 525
Ethanol [H3O] 83 186
Propanol [H3O] 43 23
Hydrogen cyanide [H3O] 28 9
Isoprene [NO] 66,68 184
Acetic acid [NO] 90 107
Ammonia [O2] 17,35 1192
aTotal number of product ion counts registered during a 60 s MIM mo
bAverage predicted measurement error determined from the total num
cBias, mean difference between repeated measures.
dPrecision, standard deviation of the differences between repeated me
eRc  Lin’s concordance correlation coefficient.
fCv  mean coefficient of variability.in Table 1.collected using a standardized sampling methodology
(Mann Whitney U test; P  0.03). With the possible
exception of acetic acid, whose origin within the respi-
ratory tree is yet to be confirmed, these metabolites are
released in significant quantities from the oral cavity
[3]. Findings might therefore suggest that the adoption
of a standardized protocol, in particular the use of a
restricted expiratory flow rate, leads to enrichment of
the levels of orally generated breath metabolites. One
possible explanation for this is that at lower expiratory
flow rates the duration over which volatile metabolites
are permitted to diffuse between the oral mucosa and
gas phase is prolonged.
In contrast with the results for Cv, the standard
deviation of intra-subject differences in repeat breath
samples, presented in Table 2 as precision, tended to
be greater for standardized compared with non-
standardized breath samples. Further analysis revealed
that differences were related to greater inter-subject
variability in standardized experiments. Explanation of
these results is likely to concern the influence of addi-
f variability, Cv (%), as function of (a) total
ered for the different breath metabolites listed
n Predicted errorb Biasc Precisiond
Rce Cvfcounta (ppb) (ppb) (ppb)
478 21 16 52 0.99 0.01
12 56 53 124 0.52 0.07
16 4 3 8 0.70 0.06
11 3 2 5 0.39 0.19
51 31 8 30 0.94 0.02
14 29 25 98 0.37 0.07
310 85 44 311 0.98 0.01
an.
f counts (generated by SIFT-MS software, see Reference [7]).
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quire further investigation.
Experiment III
The repeatability of off-line mixed and alveolar breath
sampling was assessed. Median values and repeatabil-
ity statistics are presented in Table 3. Off-line measure-
ment of acetone showed excellent repeatability in both
mixed and alveolar samples. With the exception of
acetic acid, alveolar breath sampling tended to improve
repeatability of the analysis, while differences between
Cv values for the two sampling approaches were less
marked. The finding, in selected cases, of superior
precision compared with results presented in Table 1 is
attributed to the diminished influence of inter-subject
variability.
The concentration of ethanol was observed to be
higher within mixed compared with alveolar breath
(P  0.01) suggesting its release is predominantly
from those regions of the respiratory tract that are
not involved in gas exchange, including the oral
cavity and larger airways. Whilst the opposite rela-
tionship was seen for isoprene, this failed to reach
statistical significance (P  0.05). It is therefore grat-
ifying that current findings agree with the reports of
previous authors who demonstrate ethanol and iso-
prene to be primarily of oral and systemic origin,
respectively [3, 8].
Table 2. Repeatability of non-standardized [NS] and standardiz
Median (ppb) Precis
NS S NS
Acetone 598 507 73
Ethanol 58 208 136
Propanol 15 28 12
Hydrogen cyanide 13 34 12
Isoprene 281 251 118
Acetic acid 77 145 64
Ammonia 1007 1433 184
aPrecision, standard deviation of the difference between repeated mea
bRc  Lin’s concordance correlation coefficient.
cCv  mean intra-individual coefficient of variability.
Table 3. Repeatability of SIFT-MS analysis of mixed [M] and al
Median (ppb) Preci
M A M
Acetone 548 542 81
Ethanol 203 108 63
Propanol 22 17 15
Hydrogen cyanide 10 10 10
Isoprene 213 274 63
Acetic acid 139 116 53
Ammonia 1216 1301 827
aPrecision, standard deviation of the differences between repeated me
bRc  Lin’s concordance correlation coefficient.
cCv  mean intra-individual coefficient of variability.In spite of the findings presented herein, there re-
mains limited consensus as to the requirement for
standardized practices within the field of exhaled
breath analysis. It is unlikely that the adoption of
guidelines similar to those proposed by the American
Thoracic and European Respiratory Societies for the
measurement of exhaled nitric oxide [9] will be justified
for the majority of exhaled metabolites. Should stan-
dardization of the measurement of selected breath
metabolites be thought necessary in the future, a greater
understanding of their source of origin within the
respiratory tree as well as knowledge of a defined
association with both healthy and disease states is
required. Further work is now needed to determine the
influence of these factors as well as to more clearly
define the effects of different sampling methodologies
on the detection of exhaled metabolites. Allied with
these investigations, continued refinement of the
SIFT-MS technique, in particular improved sensitivity,
will help support the analysis of volatile metabolites in
the low ppb range and beyond.
A limitation of this study is that observations were
made from only a relatively small number of healthy
subjects. Whether findings are applicable to metabolites
analyzed within the breath of patients with disease
states remains unknown. Further work is needed to
understand the relationship between pathologic status
and measurement repeatability.
] VOC analysis by SIFT-MS
(ppb) Rcb Cvc
S NS S NS S
78 0.43 0.90 0.02 0.02
165 0.22 0.12 0.89 0.55
17 0.07 0.66 0.53 0.12
16 0.44 0.89 0.45 0.09
150 0.73 0.90 0.25 0.09
80 0.17 0.08 0.90 0.40
160 0.88 0.90 0.03 0.02
, calculated as: 2/3*(breath 1–breath 3).
r [A] breath samples
(ppb) Rcb Cvc
A M A M A
102 0.96 0.94 0.01 0.01
62 0.41 0.59 0.05 0.06
5 0.60 0.71 0.08 0.05
5 0.18 0.68 0.23 0.17
86 0.67 0.79 0.17 0.17
55 0.69 0.21 0.05 0.06
791 0.27 0.67 0.04 0.04
ments.ed [S
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This study presents new evidence of the short-term
repeatability of SIFT-MS analysis of prominent breath
metabolites detected over a wide concentration range.
For those metabolites investigated, this technique is
both reliable and repeatable. Whilst sampling method-
ology does appear to have a role in influencing the level
of observed repeatability and variability, metabolite
concentration and physiologic variability remain the
principal determinants of these parameters. Patterns of
intra- and inter-individual variability in healthy sub-
jects that are presented are intended to support inter-
pretation of changes brought about by pathologic states,
in turn helping to establish mass spectrometry-based
methods within the clinical setting. Future work is now
needed to determine the influence of other sampling
methodologies as well as disease status on the day-to-
day variation in exhaled metabolite levels.
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